ArticleFrontiers in chemistry2026
Visible-light-induced trifluoroacetylation reaction of electron-deficient nitrogen heterocycles.
Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The direct C-H trifluoroacetylation of electron-deficient nitrogen heterocycles remains a longstanding challenge with conventional reagents, owing to the inherent instability of the trifluoroacetyl radical and its polarity mismatch with electron-deficient substrates. Here, a novel method for the trifluoroacetylation of electron-deficient nitrogen heterocycles has been developed; under visible-light irradiation, the protocol operates without the need for cumbersome substrate pre-functionalization, expensive catalysts, transition metals, or additional additives. This approach enables the efficient trifluoroacetylation of diverse substrates, including pyridine, quinoline, quinoxalinone, chromone, and azauracil, and exhibits broad functional group tolerance and versatility, rendering it highly suitable for the late-stage functionalization of various bioactive molecules. By overcoming the polarity-mismatch limitation, this strategy addresses the longstanding challenge of direct C-H trifluoroacetylation of electron-deficient nitrogen heterocycles and aligns with the principles of sustainable chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.